STATE LEVEL DRUG CONTROLLERS

Cardiac packages may get dearer after stent price cut

The crackdown on hospitals for overpricing stents has broadened into a multi-agency exercise with state-level drug controllers being roped in to check inventories.There are also plans to send in decoy patients and keep an eye on hospital billing data through insurers to ensure compliance.